Deal to make Covid drug available to 3.8B folk set

By Agence France-Presse

Nov 18, 2021 12:08 am

GENEVA: US pharmaceutical giant Pfizer on Tuesday (Wednesday in Manila) announced a deal to make its prospective antiviral Covid-19 pill available more cheaply in the world's least-wealthy countries.

Pfizer will sublicense production of its promising Paxlovid pill to generic drug manufacturers for supply in 95 low- and middle-income nations covering around 53 percent (around 3.8 billion) of the world's population.

Already have an active account? Log in here to continue reading.
Or
Subscribe to the Premium Subscription plan to access this subscriber-exclusive article.

Related Articles

'Let out your inner granny:' Knits at the flicks craze grips Vienna

Delta passengers dangled from seats as plane flipped over

Musk has no formal decision-making authority – White House

Researchers link a gene to the emergence of spoken language

Cambodian lawmakers pass law against Khmer Rouge genocide denial

UN nuclear chief to view contaminated Fukushima soil

Musk launches 'scary smart' AI chatbot